TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Conditions
Breast - Female | Breast
Phase III
Volunteers
Health Professionals
What is the purpose of this trial?
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
- Trial withCanadian Cancer Trials Group CCTG
- Start Date05/06/2019
- End Date09/01/2027
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
Sub-Investigators
- Abhijit Patel, MD, PhD
- Andrea Brennan
- Andrea Silber, MD
- Armand Russo, MD
- Benjamin Newton, MD
- Bruce A. McGibbon, MD
- David Witt, MD
- Elan Gorshein, DO, JD, MPH
- Erin Hofstatter, MD
- Gregory Zanieski, FACS, MD
- Harold Tara Jr, MD
- Henry S. Park, MD, MPH
- Jane Kanowitz, MD
- Jason Haldas, MD
- Jeremy Kortmansky, MD
- Justin Persico, MD
- Kathleen Fenn, MD
- Kerin Adelson, MD
- Kimberly L. Johung, MD, PhD
- Kristen Hoxie
- Lajos Pusztai, DPhil, MD
- Lynn D. Wilson, FASTRO, MD, MPH
- Meena S. Moran, MD
- Melissa Rasar Young, MD, PhD
- Michael Cohenuram, MD
- Michael DiGiovanna, MD, PhD
- Neal Fischbach, MD
- Robert Legare, MD
- Roy H. Decker, MD/PhD
- Sara Anastasio, RN
- Sarah Carlson
- Sarah Elizabeth Schellhorn, MD
- Shari Damast, MD
- Stephen Lattanzi, MD
- Su Hsien Lim, MD
- Suzanne B. Evans, FASTRO, MD, MPH
- Tara Sanft, MD
- Virginia Syombathy
- Wajih Kidwai, FACP, MD
- Last Updated11/11/2022
- Study HIC#2000023958